News

Bulimia Nervosa is a binge eating disorder. Currently, Lightlake is focused on providing a safe, effective and simple treatment for patients with Bulimia Nervosa as well as those

Ramelteon works by selectively targeting two melatonin receptors in the brain MT1 and MT2 to regulate body’s sleep-wake cycle and treat insomnia. TGRD Europe has withdrawn its Marketing

The randomized LYM-3001 trial which enrolled 676 patients with relapsed follicular lymphoma received Velcade and rituximab or rituximab alone. The primary endpoint of the trial was progression-free survival

Abraxane, developed using nab technology platform, is a solvent-free chemotherapy treatment option for metastatic breast cancer. The study comprised evaluation of Abraxane in combination with gemcitabine in 67

Cialis inhibits an enzyme, phosphodiesterase type 5 (PDE5), producing vascular relaxation and increased blood flow. Cialis was assessed in a clinical trial program of three placebo-controlled efficacy and

The inhaler, Salmeterol pMDI does not contain Chlorofluorocarbon (CFC) which can cause environmental damage. The product comes in 25mcg per actuation pressurised inhalation, suspension in a green inhaler.

The company has posted a net income of EUR19.2m for the quarter, indicating a rise by 36% ascompared to the corresponding period of the previous year. Adjusted earnings

The initial Cannabis extract-based products, which are being manufactured, will be made available to licensed medical marijuana patients in Colorado. Later, the prodcuts will be expanded across the

According to the company, the funding comes on the heels of a recent $19m fundraising that was completed in April. CoDa develops and commerciales therapeutics for wound care,